• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗菌肽的设计:以人源抗菌肽 LL-37 为模型的研究进展。

Design of Antimicrobial Peptides: Progress Made with Human Cathelicidin LL-37.

机构信息

Department of Pathology and Microbiology, College of Medicine, University of Nebraska Medical Center, Omaha, NE, USA.

出版信息

Adv Exp Med Biol. 2019;1117:215-240. doi: 10.1007/978-981-13-3588-4_12.

DOI:10.1007/978-981-13-3588-4_12
PMID:30980360
Abstract

The incorporation of the innate immune system into humans is essential for survival and health due to the rapid replication of invading microbes and the delayed action of the adaptive immune system. Antimicrobial peptides are important components of human innate immunity. Over 100 such peptides have been identified in various human tissues. Human cathelicidin LL-37 is best studied, and there has been a growing interest in designing new peptides based on LL-37. This chapter describes the alternative processing of the human cathelicidin precursor, protease digestion, and lab cutting of LL-37. Both a synthetic peptide library and structure-based design are utilized to identify the active regions. Although challenging, the determination of the 3D structure of LL-37 enabled the identification of the core antimicrobial region. The minimal region of LL-37 can be function-dependent. We discuss the design and potential applications of LL-37 into antibacterial, antibiofilm, antiviral, antifungal, immune modulating, and anticancer peptides. LL-37 has been engineered into 17BIPHE2, a stable, selective, and potent antimicrobial, antibiofilm, and anticancer peptide. Both 17BIPHE2 and SAAP-148 can eliminate the ESKAPE pathogens and show topical in vivo antibiofilm efficacy. Also discussed are other application strategies, including peptide formulation, antimicrobial implants, and peptide-inducing factors such as vitamin D and sunlight. Finally, we summarize what we learned from peptide design based on human LL-37.

摘要

由于入侵微生物的快速复制和适应性免疫系统的延迟作用,人体先天免疫系统的融入对于生存和健康至关重要。抗菌肽是人体先天免疫系统的重要组成部分。在各种人体组织中已经鉴定出超过 100 种此类肽。人类防御素 LL-37 研究得最为透彻,人们越来越有兴趣基于 LL-37 设计新的肽。本章描述了人类防御素前体的替代加工、蛋白酶消化和 LL-37 的实验室切割。既利用了合成肽文库,也利用了基于结构的设计来识别活性区域。尽管具有挑战性,但确定 LL-37 的 3D 结构使得能够识别核心抗菌区域。LL-37 的最小区域可能是功能依赖性的。我们讨论了将 LL-37 设计成具有抗菌、抗生物膜、抗病毒、抗真菌、免疫调节和抗癌作用的肽的应用。LL-37 已被设计成 17BIPHE2,这是一种稳定、选择性和有效的抗菌、抗生物膜和抗癌肽。17BIPHE2 和 SAAP-148 都可以消除 ESKAPE 病原体,并显示出局部体内抗生物膜功效。还讨论了其他应用策略,包括肽制剂、抗菌植入物以及维生素 D 和阳光等肽诱导因子。最后,我们总结了从基于人类 LL-37 的肽设计中获得的经验教训。

相似文献

1
Design of Antimicrobial Peptides: Progress Made with Human Cathelicidin LL-37.抗菌肽的设计:以人源抗菌肽 LL-37 为模型的研究进展。
Adv Exp Med Biol. 2019;1117:215-240. doi: 10.1007/978-981-13-3588-4_12.
2
Modulation of antimicrobial potency of human cathelicidin peptides against the ESKAPE pathogens and in vivo efficacy in a murine catheter-associated biofilm model.调控人源抗菌肽对 ESKAPE 病原体的抗菌效力及其在小鼠导管相关生物膜模型中的体内疗效。
Biochim Biophys Acta Biomembr. 2019 Sep 1;1861(9):1592-1602. doi: 10.1016/j.bbamem.2019.07.012. Epub 2019 Jul 15.
3
Short and Robust Anti-Infective Lipopeptides Engineered Based on the Minimal Antimicrobial Peptide KR12 of Human LL-37.基于人LL-37最小抗菌肽KR12设计的短而强效的抗感染脂肽
ACS Infect Dis. 2021 Jun 11;7(6):1795-1808. doi: 10.1021/acsinfecdis.1c00101. Epub 2021 Apr 23.
4
Tissue-specific Regulation of Innate Immune Responses by Human Cathelicidin LL-37.人源抗菌肽 LL-37 对固有免疫应答的组织特异性调节
Curr Pharm Des. 2018;24(10):1079-1091. doi: 10.2174/1381612824666180327113418.
5
High-quality 3D structures shine light on antibacterial, anti-biofilm and antiviral activities of human cathelicidin LL-37 and its fragments.高质量的3D结构揭示了人源抗菌肽LL-37及其片段的抗菌、抗生物膜和抗病毒活性。
Biochim Biophys Acta. 2014 Sep;1838(9):2160-72. doi: 10.1016/j.bbamem.2014.01.016. Epub 2014 Jan 23.
6
17BIPHE2, an engineered cathelicidin antimicrobial peptide with low susceptibility to proteases, is an effective spermicide and microbicide against Neisseria gonorrhoeae.17BIPHE2 是一种经过工程改造的抗菌肽,对蛋白酶的敏感性较低,是一种有效的杀精剂和淋病奈瑟菌杀菌剂。
Hum Reprod. 2022 Oct 31;37(11):2503-2517. doi: 10.1093/humrep/deac188.
7
Peptide Stability Is Important but Not a General Requirement for Antimicrobial and Antibiofilm Activity In Vitro and In Vivo.肽稳定性很重要,但并非体外和体内抗菌及抗生物膜活性的普遍要求。
Mol Pharm. 2023 Jan 2;20(1):738-749. doi: 10.1021/acs.molpharmaceut.2c00918. Epub 2022 Dec 9.
8
The human cathelicidin hCAP18/LL-37: a multifunctional peptide involved in mycobacterial infections.人源抗菌肽 hCAP18/LL-37:参与分枝杆菌感染的多功能肽。
Peptides. 2010 Sep;31(9):1791-8. doi: 10.1016/j.peptides.2010.06.016. Epub 2010 Jun 25.
9
Unique features of human cathelicidin LL-37.人源杀菌肽LL-37的独特特征。
Biofactors. 2015 Sep-Oct;41(5):289-300. doi: 10.1002/biof.1225. Epub 2015 Oct 5.
10
Antimicrobial and antibiofilm activity of cathelicidins and short, synthetic peptides against Francisella.抗菌肽和短合成肽对弗朗西斯菌的抗菌和抗生物膜活性。
Biochem Biophys Res Commun. 2010 May 28;396(2):246-51. doi: 10.1016/j.bbrc.2010.04.073. Epub 2010 Apr 23.

引用本文的文献

1
Antimicrobial Peptides of the Cathelicidin Family: Focus on LL-37 and Its Modifications.cathelicidin家族抗菌肽:聚焦LL-37及其修饰
Int J Mol Sci. 2025 Aug 21;26(16):8103. doi: 10.3390/ijms26168103.
2
The Role of Vitamin D and Vitamin D Receptor in Sepsis.维生素D及维生素D受体在脓毒症中的作用
Curr Issues Mol Biol. 2025 Jul 1;47(7):500. doi: 10.3390/cimb47070500.
3
Identification and characterization of amphipathic antimicrobial peptides with broad spectrum activity against multi-drug resistant bacteria.具有抗多药耐药菌广谱活性的两亲性抗菌肽的鉴定与表征
Curr Res Microb Sci. 2025 Feb 13;8:100363. doi: 10.1016/j.crmicr.2025.100363. eCollection 2025.
4
Emerging antimicrobial therapies for Gram-negative infections in human clinical use.目前正在临床应用的针对革兰氏阴性菌感染的新型抗菌疗法。
NPJ Antimicrob Resist. 2025 Feb 27;3(1):16. doi: 10.1038/s44259-025-00087-2.
5
CLEC3A-Derived Antimicrobial Peptides Reduce Bacterial Counts in an In Vivo Biomaterial-Associated Infection Mouse Model.CLEC3A衍生的抗菌肽可降低体内生物材料相关感染小鼠模型中的细菌数量。
Pharmaceutics. 2025 Feb 12;17(2):234. doi: 10.3390/pharmaceutics17020234.
6
Cathelicidins: Opportunities and Challenges in Skin Therapeutics and Clinical Translation.Cathelicidins:皮肤治疗与临床转化中的机遇与挑战
Antibiotics (Basel). 2024 Dec 24;14(1):1. doi: 10.3390/antibiotics14010001.
7
Antimicrobial peptides and proteins against drug-resistant pathogens.抗耐药病原体的抗菌肽和蛋白质。
Cell Surf. 2024 Nov 27;12:100135. doi: 10.1016/j.tcsw.2024.100135. eCollection 2024 Dec.
8
Conjugated therapeutic proteins as a treatment for bacteria which trigger cancer development.结合治疗性蛋白质作为治疗引发癌症发展的细菌的一种方法。
iScience. 2024 Sep 26;27(10):111029. doi: 10.1016/j.isci.2024.111029. eCollection 2024 Oct 18.
9
Novel Tree Shrew-Derived Antimicrobial Peptide with Broad-Spectrum Antibacterial Activity.具有广谱抗菌活性的新型树鼩源抗菌肽
ACS Omega. 2024 Oct 30;9(45):45279-45288. doi: 10.1021/acsomega.4c06857. eCollection 2024 Nov 12.
10
Origami of KR-12 Designed Antimicrobial Peptides and Their Potential Applications.KR-12设计的抗菌肽的折纸结构及其潜在应用。
Antibiotics (Basel). 2024 Aug 28;13(9):816. doi: 10.3390/antibiotics13090816.